Ann: Correction to ASX announcement, page-8

I'll put my 2 cents worth in here . I've been invested in RAP since mid 2018.As with any early stage health care stock or any other stock you take your chances , you may lose all your investment ,it may be mediocre or it may fly . We as shareholders have been given every indication by management that we are on a winner ,the current customers are very happy with the way things are going and management are happy with progress and figures around $1 + have been thrown around by management . Pfizer come along ,suddenly 11+cents is a really good offer and the board whole heartily endorses it , the shareholders revolt as a large ? % of them are well under water , so Pfizer come back with 14+cent offer which the board fully supports , they (I assume ) closely monitor how the vote is going , realise it is not going to get over the line so up the offer to 20.8 cents which the board fully supports or possible a competing offer came in and Pfizer decided to match or raise .,the board fully support the new offer .You can decide for yourself if the board had no idea of what the share price should be $1 , 11+ cents , 14+ cents 20+cents or have they painted themselves into a corner and can't get out .It is my opinion that if RAP wasn't worth at least 10 and I expect much more than that, times Pfizer's latest offer then they would not have had any interest in it to start with . In my humble opinion Pfizer has not come close to what they would be prepared to pay and current and maybe more so long term supporting shareholders should not have to accept a loss or bank interest on what is obviously a successful product or Pfizer would have no interest in it in the first place .whether you are a long term holder , a recent holder or an arbitrage trader it would be in all your interests to vote no as it is very clear Pfizer is not walking away . this is my opinion only and not financial advice